⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for nasopharyngeal carcinoma (npc)

Every month we try and update this database with for nasopharyngeal carcinoma (npc) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)NCT03769467
Nasopharyngeal ...
Nasopharyngeal ...
Epstein-Barr Vi...
Epstein-Barr Vi...
Epstein-Barr Vi...
tabelecleucel
pembrolizumab
12 Years - Atara Biotherapeutics
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNANCT02363400
Nasopharyngeal ...
MEP
20 Years - National Health Research Institutes, Taiwan
Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal CarcinomaNCT01536223
Chemoradiation
Nasopharyngeal ...
PF (cisplatin a...
TPF (docetaxel ...
18 Years - 70 YearsZhejiang Cancer Hospital
Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal CarcinomaNCT01536223
Chemoradiation
Nasopharyngeal ...
PF (cisplatin a...
TPF (docetaxel ...
18 Years - 70 YearsZhejiang Cancer Hospital
Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRTNCT02735317
Nasopharyngeal ...
Stomatitis
Oral Ulcer Garg...
Quadruple mixtu...
18 Years - 65 YearsSun Yat-sen University
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsNCT02578641
Nasopharyngeal ...
autologous EBV ...
combination IV ...
18 Years - Tessa Therapeutics
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid TumorsNCT04215978
Advanced Solid ...
Non Small Cell ...
Head and Neck S...
Nasopharyngeal ...
BGB-A445
tislelizumab
18 Years - BeiGene
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)NCT03769467
Nasopharyngeal ...
Nasopharyngeal ...
Epstein-Barr Vi...
Epstein-Barr Vi...
Epstein-Barr Vi...
tabelecleucel
pembrolizumab
12 Years - Atara Biotherapeutics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: